These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Vasopeptidase inhibition: a new concept in blood pressure management. Burnett JC J Hypertens Suppl; 1999 Feb; 17(1):S37-43. PubMed ID: 10340842 [TBL] [Abstract][Full Text] [Related]
6. Effects of omapatrilat on pharmacodynamic biomarkers of neutral endopeptidase and Angiotensin-converting enzyme activity in humans. Vesterqvist O; Reeves RA Curr Hypertens Rep; 2001 Dec; 3 Suppl 2():S22-7. PubMed ID: 11716802 [TBL] [Abstract][Full Text] [Related]
7. Vasopeptidase inhibitors: potential role in the treatment of heart failure. Trindade PT; Rouleau JL Heart Fail Monit; 2001; 2(1):2-7. PubMed ID: 12634892 [TBL] [Abstract][Full Text] [Related]
8. Vasopeptidase inhibition and endothelial function in hypertension. d'Uscio LV; Lüscher TF Curr Hypertens Rep; 2001 Dec; 3 Suppl 2():S6-14. PubMed ID: 11716800 [TBL] [Abstract][Full Text] [Related]
9. The natriuretic peptide neurohormonal system modulation by vasopeptidase inhibitors--the novel therapeutical approach of hypertension treatment. Machowska A; Juszczak K; Novak P; Thor P Folia Med Cracov; 2009; 50(3-4):35-42. PubMed ID: 21853869 [TBL] [Abstract][Full Text] [Related]
10. Vasopeptidase inhibitors, neutral endopeptidase inhibitors, and dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase. Nawarskas J; Rajan V; Frishman WH Heart Dis; 2001; 3(6):378-85. PubMed ID: 11975822 [TBL] [Abstract][Full Text] [Related]
11. Evidence for cardioprotective, renoprotective, and vasculoprotective effects of vasopeptidase inhibitors in disease. Kubota E; Dean RG; Hubner RA; Balding LC; Johnston CI; Burrell LM Curr Hypertens Rep; 2001 Dec; 3 Suppl 2():S31-3. PubMed ID: 11716804 [TBL] [Abstract][Full Text] [Related]
12. Towards triple vasopeptidase inhibitors for the treatment of cardiovascular diseases. Daull P; Jeng AY; Battistini B J Cardiovasc Pharmacol; 2007 Sep; 50(3):247-56. PubMed ID: 17878751 [TBL] [Abstract][Full Text] [Related]
13. Vasopeptidase inhibition: a double-edged sword? Campbell DJ Hypertension; 2003 Mar; 41(3):383-9. PubMed ID: 12623931 [TBL] [Abstract][Full Text] [Related]
14. [Vasopeptidase inhibition: a new pharmacological principle in the treatment of hypertension and cardiac insufficiency]. Kolloch R; Offers E Dtsch Med Wochenschr; 2001 Nov; 126(47):1342-7. PubMed ID: 11719860 [No Abstract] [Full Text] [Related]
15. Dual ACE and neutral endopeptidase inhibitors: novel therapy for patients with cardiovascular disorders. Tabrizchi R Drugs; 2003; 63(20):2185-202. PubMed ID: 14498755 [TBL] [Abstract][Full Text] [Related]